Last reviewed · How we verify
Etrynit (propatylnitrate)
Etrynit (generic name: propatylnitrate) is a Vasodilators Organic Nitrates drug. It is currently in unknown development.
Etrynit works by releasing nitric oxide, which relaxes blood vessel muscles and causes blood vessels to dilate.
Etrynit is a small molecule medication with the synonyms ETRYNIT, ETT-N, ETTN, PROPATILNITRATO, PROPATYL NITRATE, and PROPATYL NITRATE. It is used as a nitrovasodilator to treat angina pectoris.
At a glance
| Generic name | propatylnitrate |
|---|---|
| Drug class | Vasodilators Organic Nitrates |
| Therapeutic area | Hematology |
| Phase | unknown |
Mechanism of action
Think of it like a valve in a hose. When the valve is open, water flows freely. In the case of Etrynit, the 'valve' is the blood vessel muscle. When nitric oxide is released, it opens the valve, allowing blood to flow more easily and reducing blood pressure.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Etrynit CI brief — competitive landscape report
- Etrynit updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Etrynit
What is Etrynit?
How does Etrynit work?
What is the generic name of Etrynit?
What drug class is Etrynit in?
What development phase is Etrynit in?
Related
- Drug class: All Vasodilators Organic Nitrates drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Hematology
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing